A Role for PET/CT in Response Assessment of Malignant Pleural Mesothelioma

被引：7
|
作者：
Sandach, Patrick [1 ,2 ]
Seifert, Robert [1 ,2 ]
Fendler, Wolfgang P. [1 ,2 ]
Hautzel, Hubertus [1 ,2 ]
Herrmann, Ken [1 ,2 ]
Maier, Sandra [3 ]
Ploenes, Till [4 ]
Metzenmacher, Martin [5 ]
Ferdinandus, Justin [1 ,2 ]
机构：
[1] Univ Duisburg Essen, Dept Nucl Med, Hufelandstr 55, D-45122 Essen, Germany
[2] German Canc Consortium DKTQ Univ Hosp Essen, Dept Nucl Med, Essen, Germany
[3] Univ Hosp Essen, Dept Diagnost & Intervent Radiol, Essen, Germany
[4] Univ Duisburg Essen, Univ Med Essen Ruhrlandklin, West German Canc Ctr, Dept Thorac Surg, Essen, Germany
[5] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr WTZ, Dept Med Oncol, Essen, Germany
来源：
SEMINARS IN NUCLEAR MEDICINE | 2022年 / 52卷 / 06期
关键词：
POSITRON-EMISSION-TOMOGRAPHY; SOLID TUMORS; EVALUATION CRITERIA; LUNG-CANCER; OPEN-LABEL; COMPUTED-TOMOGRAPHY; MODIFIED RECIST; MULTICENTER; THERAPY; CHEMOTHERAPY;
D O I：
10.1053/j.semnuclmed.2022.04.008
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Malignant pleural mesothelioma is a rare type of cancer, whose incidence, however, is increasing and will presumably continue to rise in the coming years. Key features of this disease comprise its mantle-shaped, pleura-associated, often multifocal growth, which cause diagnostic challenges. A growing number of mesotheliomas are being treated with novel immunotherapies for which no image derived general response criteria have been established. However, recent studies indicate that FDG-PET/CT could be superior for response assessment compared to CT-based criteria. This article aims at providing an overview of response assessment criteria dedicated to malignant pleural mesothelioma, such as mRECIST, iRECIST, and PERCIST. In addition, the potential future role of PET/CT in the management of malignant pleural mesothelioma will also be discussed. Semin Nucl Med 52:816-823 (c) 2022 Elsevier Inc. All rights reserved.
引用
收藏
页码：816 / 823
页数：8
相关论文
共 50 条
  • [21] Prognostic Value of FDG-PET/CT in Therapy Response Evaluation of Malignant Pleural Mesothelioma
    Veit-Haibach, P.
    Schaefer, N.
    Soyka, J.
    Strobel, K.
    Hany, T.
    Steinert, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S138 - S139
  • [22] Preoperative evaluation of patients with malignant pleural mesothelioma: Role of integrated CT-PET imaging
    Truong, Mylene T.
    Marom, Edith M.
    Erasmus, Jeremy J.
    JOURNAL OF THORACIC IMAGING, 2006, 21 (02) : 146 - 153
  • [23] Is FDG-PET/CT useful for managing malignant pleural mesothelioma?
    Otsuka, Hideki
    Terazawa, Kaori
    Morita, Naomi
    Otomi, Yoichi
    Yamashita, Kyo
    Nishitani, Hiromu
    JOURNAL OF MEDICAL INVESTIGATION, 2009, 56 (1-2): : 16 - 20
  • [24] Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT
    Francis, Roslyn
    Segard, Tatiana
    Nowak, Anna
    Lee, Y. C. Gary
    Morandeau, Laurence
    Campbell, Elaine
    Millward, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [25] Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT
    Francis, Roslyn J.
    Segard, Tatiana
    Morandeau, Laurence
    Lee, Y. C. Gary
    Millward, Michael J.
    Segal, Amanda
    Nowak, Anna K.
    LUNG CANCER, 2015, 90 (01) : 55 - 60
  • [26] PET/CT in the preoperative evaluation of patients with malignant pleural mesothelioma (MPM)
    Gregianin, M.
    Rossi, F. Dei
    Cracco, E.
    Zaccaria, A.
    Canton, A.
    Pagan, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S142 - S142
  • [27] Preclinical Models and PET/CT Imaging to Study Malignant Pleural Mesothelioma
    Bejuy, O.
    Senoner, I.
    Germain, S.
    Triponez, F.
    Serre-Beinier, V.
    Colin, D. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S430 - S431
  • [28] A COMPARISON OF CT AND MRI VOLUMETRIC ASSESSMENT OF MALIGNANT PLEURAL MESOTHELIOMA
    Tsim, S.
    Cowell, G. W.
    Kidd, A.
    Woodward, R.
    Alexander, L.
    Kelly, C.
    Foster, J. E.
    Blyth, K. G.
    THORAX, 2019, 74 : A80 - A81
  • [29] Assessment of therapeutic response and prognosis in malignant pleural mesothelioma with 18F-FDG-PET
    Moriya, S.
    Oriuchi, N.
    Higuchi, T.
    Arisaka, Y.
    Takano, A.
    Endo, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S350 - S350
  • [30] The role of PET/CT in malignant mesothelioma: preliminary data
    Gogou, L.
    Kechagias, D.
    Vlachou, F.
    Filipi, V.
    Tsevas, D.
    Kotsalou, E.
    Gogos, K.
    Dalianis, K.
    Andreou, J.
    Prassopoulos, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S333 - S333
12345